文献速递重症综合管理与镇静镇痛

神经肌肉电刺激预防危重患者压力性损伤的疗效与安全性:一项随机对照试验

Efficacy and safety of neuromuscular electrical stimulation in the prevention of pressure injuries in critically ill patients: a randomized controlled trial.
PubMed 文献 · Ann Intensive Care · 2022-06-13
一句话结论ICU内早期使用神经肌肉电刺激可使压力性损伤风险降至对照组的0.15倍,NNT=3.3,并缩短ICU住院时间1.8天。

该随机对照试验纳入149例入住ICU不足48小时、年龄≥18岁的危重患者,按1:1随机分为神经肌肉电刺激(NMES)联合常规护理组(76例)与单纯常规护理对照组,直至出院、死亡或发生压力性损伤。对照组26例(35.6%)发生压力性损伤,NMES组4例(5.3%),差异有统计学意义(p˂0.001);NMES组发生压力性损伤的相对危险度RR=0.15(95%CI 0.05-0.40),NNT=3.3(95%CI 2.3-5.9)。NMES组ICU住院时间缩短1.8±1.2天(p=0.04),两组臀大肌厚度变化无显著差异(对照组Δ=-0.37±1.2 cm vs NMES组Δ=0±0.98 cm,p=0.33)。NMES未引起生命体征不良变化,也未发现刺激部位皮肤烧伤。作者认为NMES是预防危重患者压力性损伤有效且安全的治疗,并可能缩短ICU住院时间。

要点

  • 纳入ICU不足48小时、年龄≥18岁患者,NMES联合常规护理组压力性损伤发生率5.3%(4/76)vs 对照组35.6%(26/73),p˂0.001。
  • NMES组发生压力性损伤的RR=0.15(95%CI 0.05-0.40),NNT=3.3(95%CI 2.3-5.9)。
  • NMES组ICU住院时间较对照组缩短1.8±1.2天(p=0.04)。
  • 两组臀大肌厚度变化无显著差异(对照组Δ=-0.37±1.2 cm vs NMES组Δ=0±0.98 cm,p=0.33)。
  • NMES未引起生命体征不良变化,未检测到刺激部位皮肤烧伤。

适用人群与场景

  • 纳入标准:入住ICU时间不足48小时、年龄≥18岁的危重患者。
  • 研究场景为ICU,干预持续至出院、死亡或发生压力性损伤。

处置流程与药物剂量

  • NMES组接受神经肌肉电刺激联合常规护理,对照组仅接受常规护理,直至出院、死亡或发生压力性损伤。
  • 通过超声评估臀大肌厚度;通过分析生命体征变化及检查刺激部位皮肤烧伤评估安全性。

研究设计与关键结果

  • 随机对照试验,纳入149例患者,NMES组76例,对照组73例。
  • 压力性损伤发生率:对照组35.6%(26例)vs NMES组5.3%(4例),p˂0.001。
  • NMES组发生压力性损伤的RR=0.15(95%CI 0.05-0.40),NNT=3.3(95%CI 2.3-5.9)。
  • ICU住院时间:NMES组较对照组缩短Δ=-1.8±1.2天,p=0.04。
  • 臀大肌厚度变化:对照组Δ=-0.37±1.2 cm vs NMES组Δ=0±0.98 cm,p=0.33,无显著差异。
  • 安全性:NMES未引起生命体征不良变化,未检测到皮肤烧伤。

证据类型、等级与局限

  • 证据类型:随机对照试验。
  • 试验注册号RBR-8nt9m4,于2018年7月20日前瞻性注册。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为NMES是预防危重患者压力性损伤有效且安全的治疗,并可能缩短ICU住院时间。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Pressure injuries (PIs), especially in the sacral region are frequent, costly, and increase morbidity and mortality of patients in an intensive care unit (ICU). These injuries can occur as a result of prolonged pressure and/or shear forces. Neuromuscular electrical stimulation (NMES) can increase muscle mass and improve local circulation, potentially reducing the incidence of PI.

METHODS: We performed a randomized controlled trial to assess the efficacy and safety of NMES in preventing PI in critically ill patients. We included patients with a period of less than 48 h in the ICU, aged ≥ 18 years. Participants were randomly selected (1:1 ratio) to receive NMES and usual care (NMES group) or only usual care (control group-CG) until discharge, death, or onset of a PI. To assess the effectiveness of NMES, we calculated the relative risk (RR) and number needed to treat (NNT). We assessed the muscle thickness of the gluteus maximus by ultrasonography. To assess safety, we analyzed the effects of NMES on vital signs and checked for the presence of skin burns in the stimulated areas. Clinical outcomes were assessed by time on mechanical ventilation, ICU mortality rate, and length of stay in the ICU.

RESULTS: We enrolled 149 participants, 76 in the NMES group. PIs were present in 26 (35.6%) patients in the CG and 4 (5.3%) in the NMES group (p ˂ 0.001). The NMES group had an RR = 0.15 (95% CI 0.05-0.40) to develop a PI, NNT = 3.3 (95% CI 2.3-5.9). Moreover, the NMES group presented a shorter length of stay in the ICU: Δ = - 1.8 ± 1.2 days, p = 0.04. There was no significant difference in gluteus maximus thickness between groups (CG: Δ = - 0.37 ± 1.2 cm vs. NMES group: Δ = 0 ± 0.98 cm, p = 0.33). NMES did not promote deleterious changes in vital signs and we did not detect skin burns.

CONCLUSIONS: NMES is an effective and safe therapy for the prevention of PI in critically ill patients and may reduce length of stay in the ICU. Trial registration RBR-8nt9m4. Registered prospectively on July 20th, 2018, https://ensaiosclinicos.gov.br/rg/RBR-8nt9m4.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Baron MV, Silva PE, Koepp J, et al. Efficacy and safety of neuromuscular electrical stimulation in the prevention of pressure injuries in critically ill patients: a randomized controlled trial. Ann Intensive Care. 2022. PMID: 35695996. doi:10.1186/s13613-022-01029-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。